546 related articles for article (PubMed ID: 26202243)
1. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
2. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
[TBL] [Abstract][Full Text] [Related]
3. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
[TBL] [Abstract][Full Text] [Related]
5. Novel Small Molecule Entry Inhibitors of Ebola Virus.
Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
[TBL] [Abstract][Full Text] [Related]
6. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
[TBL] [Abstract][Full Text] [Related]
7. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
[TBL] [Abstract][Full Text] [Related]
9. The Inability of Marburg Virus to Cause Disease in Ferrets Is Not Solely Linked to the Virus Glycoprotein.
Schiffman Z; Garnett L; Tran KN; Cao W; He S; Emeterio K; Tierney K; Azaransky K; Strong JE; Banadyga L
J Infect Dis; 2023 Nov; 228(Suppl 7):S594-S603. PubMed ID: 37288605
[TBL] [Abstract][Full Text] [Related]
10. Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors.
Anantpadma M; Kouznetsova J; Wang H; Huang R; Kolokoltsov A; Guha R; Lindstrom AR; Shtanko O; Simeonov A; Maloney DJ; Maury W; LaCount DJ; Jadhav A; Davey RA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4471-81. PubMed ID: 27161622
[TBL] [Abstract][Full Text] [Related]
11. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
12. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
Guito JC; Albariño CG; Chakrabarti AK; Towner JS
Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
[TBL] [Abstract][Full Text] [Related]
13. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
[TBL] [Abstract][Full Text] [Related]
14. Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.
Yermolina MV; Wang J; Caffrey M; Rong LL; Wardrop DJ
J Med Chem; 2011 Feb; 54(3):765-81. PubMed ID: 21204524
[TBL] [Abstract][Full Text] [Related]
15. Ebola and Marburg virus vaccines.
Reynolds P; Marzi A
Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
[TBL] [Abstract][Full Text] [Related]
16. Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.
Beck S; Henß L; Weidner T; Herrmann J; Müller R; Chao YK; Grimm C; Weber C; Sliva K; Schnierle BS
Antiviral Res; 2016 Aug; 132():85-91. PubMed ID: 27241689
[TBL] [Abstract][Full Text] [Related]
17. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.
Hofmann-Winkler H; Gnirß K; Wrensch F; Pöhlmann S
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S172-80. PubMed ID: 25840443
[TBL] [Abstract][Full Text] [Related]
20. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
Hoffmann M; Crone L; Dietzel E; Paijo J; González-Hernández M; Nehlmeier I; Kalinke U; Becker S; Pöhlmann S
J Virol; 2017 May; 91(9):. PubMed ID: 28228590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
